These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33808155)

  • 1. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
    Lee NH; Kim SJ; Hyun J
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
    Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression.
    Mondal V; Higgins PJ; Samarakoon R
    Cancers (Basel); 2024 Aug; 16(15):. PubMed ID: 39123485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine.
    Sadri F; Hosseini SF; Rezaei Z; Fereidouni M
    Genes Dis; 2024 Mar; 11(2):760-771. PubMed ID: 37692482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
    Wang Y; Chen H; Yu J; Kang W; To KF
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation.
    Ji X; Song L; Sheng L; Gao A; Zhao Y; Han S; Zhang Y; Zhu C; Zhao S; Wang Z; Xu B; Li L; Li J; Tan N; Zhao B
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30453531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.
    Hayashi H; Uemura N; Zhao L; Matsumura K; Sato H; Shiraishi Y; Baba H
    Front Oncol; 2021; 11():700315. PubMed ID: 34395269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
    Yamaguchi H; Taouk GM
    Front Oncol; 2020; 10():928. PubMed ID: 32596154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis.
    Li M; Zhang FJ; Bai RJ
    J Inflamm Res; 2024; 17():1105-1120. PubMed ID: 38406325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.
    Zhang Y; Wang Y; Ji H; Ding J; Wang K
    J Exp Clin Cancer Res; 2022 Jun; 41(1):202. PubMed ID: 35701841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.